North Dakota
CNS clinical trials in North Dakota
9 CNS studies are recruiting participants at sites in 3 cities across North Dakota as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every North Dakota city with a recruiting study
By research area: Parkinson's Disease (5), Depression (2), Migraine (1), Multiple Sclerosis (1).
Fargo (7), Bismarck (2), Grand Forks (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Depression: recently updated in North Dakota
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
E-Mindfulness Approaches for Living After Breast Cancer
- Phase 3
- Ages 18 to 50
- All sexes
- Sponsor
- NRG Oncology
- Recruiting in
- Bismarck · Fargo
- Registry record
- NCT06748222 · updated
Effectiveness, Implementation, and Cost of Cognitive Processing Therapy in Prisons
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- University of Arkansas
- Recruiting in
- Bismarck
- Registry record
- NCT06923423 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in North Dakota on ClinicalTrials.gov.
Parkinson's disease: recently updated in North Dakota
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Grand Forks
- Registry record
- NCT06966700 · updated
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Fargo
- Registry record
- NCT07252739 · updated
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Fargo
- Registry record
- NCT04165070 · updated
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Fargo
- Registry record
- NCT04165798 · updated
Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD
- No phase
- All ages
- All sexes
- Sponsor
- Sanford Health
- Recruiting in
- Fargo
- Registry record
- NCT06883266 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in North Dakota on ClinicalTrials.gov.
Multiple sclerosis (MS): recently updated in North Dakota
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
- Phase 3
- Ages 40 to 70
- All sexes
- Sponsor
- Novartis Pharmaceuticals
- Recruiting in
- Fargo
- Registry record
- NCT06846281 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in North Dakota on ClinicalTrials.gov.
Migraine: recently updated in North Dakota
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Recruiting in
- Fargo
- Registry record
- NCT07816367 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in North Dakota on ClinicalTrials.gov.
Ask about studies in North Dakota
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections